Patents Assigned to Arcaris, Inc.
  • Publication number: 20030049599
    Abstract: The present invention relates to a method for performing negative selections—i.e., identifying agents that can eliminate a cell from a population. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences that encode agents which kill or arrest growth in a cell.
    Type: Application
    Filed: January 18, 2002
    Publication date: March 13, 2003
    Applicant: Arcaris, Inc.
    Inventor: C. Alexander Kamb
  • Publication number: 20020172965
    Abstract: The present invention relates to a method for the comparative assessment of the level of specific nucleic acid sequences in samples derived from different sources. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences from complex mixtures. The methods disclosed allow quantitative comparisons of the amount of nucleic acid of defined sequence in a plurality of different samples of nucleic acid, e.g., from different cells or tissues or from genetic libraries. Nucleic acids from the samples are labeled in such a fashion that the signals can be distinguished and compared following hybridization to the oligonucleotides on the beads. According to the invention, the solid supports with the hybridized nucleic acid may be retrieved, and the target nucleic acid eluted and analyzed.
    Type: Application
    Filed: February 1, 2002
    Publication date: November 21, 2002
    Applicant: Arcaris, Inc.
    Inventors: Carl Alexander Kamb, Michael John Feldhaus
  • Publication number: 20020132229
    Abstract: The present invention is directed to selection systems for the identification, by functional analysis, of cell proliferation genes that are involved in viral growth and viral disease. The invention also includes methods for identifying perturbagens and cellular targets that are involved in viral growth and viral disease.
    Type: Application
    Filed: August 14, 2001
    Publication date: September 19, 2002
    Applicant: Arcaris, Inc.
    Inventors: Carl Alexander Kamb, Mark A. Poritz
  • Publication number: 20020031790
    Abstract: Generally applicable methods for using phenotypic probes to reduce or eliminate false positives, and thereby identify physiologically relevant endogenous target molecules, are provided. The methods use both protein interaction assay steps and phenotypic assay steps. In some embodiments, protein interactions are detected utilizing yeast two hybrid techniques.
    Type: Application
    Filed: July 17, 2001
    Publication date: March 14, 2002
    Applicant: ARCARIS, INC.
    Inventor: Carl Alexander Kamb
  • Publication number: 20020019005
    Abstract: The present invention is directed to selection systems for the identification of cell proliferation genes based on functional analysis. More specifically, the invention is directed to a process for the identification of a cell proliferation promoting activity, the isolation of genes involved in such cell proliferation promoting activity, and the use of the so identified genes for the diagnosis or treatment of a disease associated with excessive cell proliferation. The invention further is directed to the design and development of antibodies, peptides, nucleic acids, and other compounds which specifically interfere with the function of the identified gene and/or its gene product, and pharmaceutical compositions comprising such compounds, for the treatment of diseases associated with inappropriate or unregulated cell proliferation.
    Type: Application
    Filed: August 2, 2001
    Publication date: February 14, 2002
    Applicant: Arcaris, Inc.
    Inventor: Carl Alexander Kamb
  • Patent number: 6060240
    Abstract: The present invention relates to a method for the comparative assessment of the level of specific nucleic acid sequences in samples derived from different sources. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences from complex mixtures. The methods disclosed allow quantitative comparisons of the amount of nucleic acid of defined sequence in a plurality of different samples of nucleic acid, e.g., from different cells or tissues or from genetic libraries. Nucleic acids from the samples are labeled in such a fashion that the signals can be distinguished and compared following hybridization to the oligonucleotides on the beads. According to the invention, the solid supports with the hybridized nucleic acid may be retrieved, and the target nucleic acid eluted and analyzed.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: May 9, 2000
    Assignee: Arcaris, Inc.
    Inventors: Alexander Kamb, Michael John Feldhaus
  • Patent number: 6025485
    Abstract: Methods and compositions for peptides or protein fragments displayed on scaffolds and libraries of sequences encoding peptides or protein fragments displayed on scaffolds that permit the properties of the library to be easily and quantitatively monitored are disclosed. The scaffold is a protein that is capable of emitting light. Thus, analysis of the expression of individual members of the library when they are expressed in cells may be carried out using instruments that can analyze the emitted light, such as flow sorter (FACS), a spectrophotometer, a microtitre plate reader, a CCD, a fluorescence microscope, or other similar device. This permits screening of the expression library in host cells on a cell-by-cell basis, and enrichment of the library for sequences that have predetermined characteristics.
    Type: Grant
    Filed: November 6, 1997
    Date of Patent: February 15, 2000
    Assignee: Arcaris, Inc.
    Inventors: Carl Alexander Kamb, Majid Abedi
  • Patent number: 5998136
    Abstract: The present invention is directed to selection systems for the identification of cell proliferation genes based on functional analysis. More specifically, the invention is directed to a process for the identification of a cell proliferation promoting activity, the isolation of genes involved in such cell proliferation promoting activity, and the use of the so identified genes for the diagnosis or treatment of a disease associated with excessive cell proliferation. The invention further is directed to the design and development of antibodies, peptides, nucleic acids, and other compounds which specifically interfere with the function of the identified gene and/or its gene product, and pharmaceutical compositions comprising such compounds, for the treatment of diseases associated with inappropriate or unregulated cell proliferation.
    Type: Grant
    Filed: August 19, 1996
    Date of Patent: December 7, 1999
    Assignee: Arcaris, Inc.
    Inventor: Carl Alexander Kamb
  • Patent number: 5955275
    Abstract: Methods for identifying nucleic acid sequences that affect a cellular phenotype are disclosed. The method uses a reporter gene whose level of expression correlates with the phenotype in conjunction with a method or device for measuring the level of reporter expression. An expression library is introduced into the cells, and those cells exhibiting changes in reporter expression level are selected. Expression library inserts from the selected cells are isolated, thereby providing a sub-library enriched for sequences that affect the phenotype reflected by the reporter. Further rounds of sub-library introduction and cell selection may be carried out to provide additional enrichment Sequences identified using this method may be used to ascertain the identity of additional molecules involved in generating the cellular phenotype.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: September 21, 1999
    Assignee: Arcaris, Inc.
    Inventor: Carl Alexander Kamb